MID-VOLUME · HOSP-HEAVY
meropenem Side Effects
meropenem (also sold as Merrem) sits MID-VOLUME #188 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 53.3% mention hospitalization (16,201 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 30,400
- FAERS reports
FDA Adverse Event Reporting System extract for meropenem. Stamp set CASELOAD · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
meropenem: 53.3% mention hospitalization (16,201 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #188 of 524 by FAERS report count.
Mid-book FAERS page for meropenem (Merrem) (30,400 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (1999–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
PYREXIA leads 2,089 of 30,400 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (8,170 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (9,111 reports, 30.0%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 1,027 |
| SEPTIC SHOCK | 941 |
| PNEUMONIA | 768 |
| SEPSIS | 755 |
| RESPIRATORY FAILURE | 653 |
| DEATH | 625 |
| PYREXIA | 599 |
| CONDITION AGGRAVATED | 468 |
| CARDIAC ARREST | 383 |
| THROMBOCYTOPENIA | 353 |
| RENAL FAILURE | 350 |
| ACUTE KIDNEY INJURY | 345 |
| DIARRHOEA | 335 |
| DRUG INEFFECTIVE FOR UNAPPROVED INDICATION | 322 |
| HYPOTENSION | 317 |
| DRUG RESISTANCE | 314 |
| FEBRILE NEUTROPENIA | 314 |
| ANAEMIA | 292 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (16,201, 53.3% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| PYREXIA | 1,469 |
| PNEUMONIA | 1,015 |
| ACUTE KIDNEY INJURY | 857 |
| SEPTIC SHOCK | 856 |
| SEPSIS | 855 |
| FEBRILE NEUTROPENIA | 810 |
| DIARRHOEA | 794 |
| RESPIRATORY FAILURE | 764 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 758 |
| CONDITION AGGRAVATED | 692 |
| THROMBOCYTOPENIA | 661 |
| ANAEMIA | 632 |
| NEUTROPENIA | 582 |
| DYSPNOEA | 577 |
| HYPOTENSION | 553 |
| DRUG INTERACTION | 513 |
| DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS | 512 |
| VOMITING | 485 |
How to read meropenem FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 30,400 voluntary reports linked to meropenem (Merrem), 1999-2025. Death is listed on 9,111 (30.0%). Hospitalization appears on 16,201 (53.3%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 53.3% mention hospitalization (16,201 reports).
Read with meropenem
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 30,089 FAERS cases (Δ 311 lighter vs meropenem); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 30,895 FAERS cases (Δ 495 heavier vs meropenem); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 29,879 FAERS cases (Δ 521 lighter vs meropenem); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 29,874 FAERS cases (Δ 526 lighter vs meropenem); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 32.1 pp vs meropenem's DEATH-HEAVY): CASELOAD · HOSP-MID.
meropenem stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.